In this time of uncertainty and turmoil, the goal of bringing new treatments to market is paramount. hyperCORE International is working with Sponsors and CROs to make this a reality at a time when it is needed the most. As one of the largest, most collaborative site networks in the world, we understand that the most important functions of today’s landscape is rapid start-up and execution of potential and current trials.

Experience and Locations

• 10,000+ COVID-19 Tests Administered Per Week.
• 5,000+ Patients a Month for Treatment Studies (Outpatient).
• 1 Million+ Overall Patient Availability.
• 100,000+ Patients Enrolled in Vaccine Trials.
• Experience in 40+ Infectious Disease Indications.
• 1,100+ Respiratory Trials Completed (Including Severe Pneumonia).

One network, One Trial Solution

• Single Contract and Centralized Budget
• Central IRBs
• All Sites Virtual Trial Certified
• Virtual/Tele/Electronic Visit Capable
• Remote and Mobile Units Available Multiple Hospital Affiliations
• Locations Across North and South America

Locations

Contact Info

mcasey@hyperCOREinternational.com

919.302.4050